Late recurrent testicular seminoma: histological evidence is required.

Authors:
Cedric Lebacle, MD
Cedric Lebacle, MD
Urology Department Bicetre University Hospital APHP Paris Sud University
Doctor
Le Kremlin Bicetre , Paris | France

Oncol Res Treat 2015 19;38(6):286-8. Epub 2015 May 19.

Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, France.

Introduction: Over the past 3 decades, the appropriate management of metastatic germ cell tumours (GCT) has been defined by several phase III trials. Many follow-up recommendations have been published based on expert consensus. However, common clinical scenarios can still be vexing for clinicians who are less experienced at managing patients with testicular cancer.

Case Report: We highlight the arduous diagnostic work-up of a suspected late relapsing metastatic GCT in a patient suffering from fatigue, weight loss and prominent retroperitoneal lymph nodes, 4 years after first-line chemotherapy for metastatic seminoma. The various explorations finally led to the diagnosis of Whipple's disease.

Conclusion: This unusual clinical case strongly highlights the need to perform an exhaustive evaluation, with a biopsy, if a late recurrent GCT is suspected to avoid pointless and potentially harmful treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000430794DOI Listing
March 2016
47 Reads

Publication Analysis

Top Keywords

late recurrent
8
clinical case
4
clinical scenarios
4
common clinical
4
scenarios vexing
4
suffering fatigue
4
explorations finally
4
clinicians experienced
4
unusual clinical
4
vexing clinicians
4
years first-line
4
consensus common
4
published based
4
seminoma explorations
4
recommendations published
4
highlights perform
4
based expert
4
case highlights
4
expert consensus
4
fatigue weight
4

Similar Publications